A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis

European Radiology

Volumn 22, Issue 12, 2012, Pages 2790-2797

  Godfrey, Edmund M ^a   Patterson, Andrew J ^b   Priest, Andrew N ^b   Davies, Susan E ^b   Joubert, Ilse ^b   Krishnan, Anant S ^b   Griffin, Nyree ^c   Shaw, Ashley S ^b   Alexander, Graeme J ^b   Allison, Michael E ^b   Griffiths, William J H ^b   Gimson, Alexander E S ^b   Lomas, David J ^d  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Elasticity imaging techniques; Hepatitis; Liver; Magnetic resonance imaging; Magnetic resonance spectroscopy

Indexed keywords

ESTER DERIVATIVE; PHOSPHODIESTER DERIVATIVE; PHOSPHOMONOESTER DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELASTOGRAPHY; FATTY LIVER; FEMALE; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LIVER BIOPSY; LIVER FIBROSIS; MAGNETIC RESNANCE ELASTOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RIGIDITY; SCORING SYSTEM;

BIOPSY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HUMANS; LIVER CIRRHOSIS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; ROC CURVE;

EID: 84870341781     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2527-x     Document Type: Article

References (42)

1. Friedman SL, Bansal MB (2006) Reversal of hepatic fibrosis - fact or fantasy? Hepatology 43:S82-S88
2. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology 49: 1017-1044
3. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A (1995) Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 36: 437-441
4. Weigand K (2009) Percutaneous liver biopsy: retrospective study over 15 years comparing 287 inpatients with 428 outpatients. J Gastroenterol Hepatol 24: 792-799
5. Regev A, Berho M, Jeffers LJ et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97: 2614-2618
6. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344: 495-500
7. Bonekamp S, Kamel I, Solga S, Clark J (2009) Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 50: 17-35
8. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269: 1854-1857
9. Rouviere O, Yin M, Dresner MA et al (2006) MR elastography of the liver: preliminary results. Radiology 240: 440-448
10. Salameh N, Larrat B, Abarca-Quinones J et al (2009) Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 253: 90-97
11. Noren B, Dahlqvist O, Lundberg P et al (2008) Separation of advanced from mild fibrosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur J Radiol 66: 313-320
12. Taylor-Robinson SD (2001) Applications of magnetic resonance spectroscopy to chronic liver disease. Clin Med 1: 54-60
13. Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38: 518-526
14. Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113-120
15. Cardoso AC, Carvalho-Filho RJ, Marcellin P (2011) Transient elastography in chronic viral hepatitis: a critical appraisal. Gut 60: 759-764
16. Maruyama H, Matsutani S, Okugawa H et al (2006) Microbubble disappearance-time is the appropriate timing for liver-specific imaging after injection of Levovist. Ultrasound Med Biol 32: 1809-1815
17. Van Beers BE, Leconte I, Materne R, Smith AM, Jamart J, Horsmans Y (2001) Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity. AJR Am J Roentgenol 176: 667-673
18. Friedrich-Rust M, Muller C, Winckler A et al (2010) Assessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MRspectroscopy, and serum markers. J Clin Gastroenterol 44: 58-65
19. Girometti R, Furlan A, Bazzocchi M et al (2007) Diffusionweighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients. Radiol Med 112: 394-408
20. Hagiwara M, Rusinek H, Lee VS et al (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 246: 926-934
21. Manduca A, Oliphant TE, Dresner MA et al (2001) Magnetic resonance elastography: non-invasive mapping of tissue elasticity. Med Image Anal 5: 237-254
22. Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129: 35-43
23. Naressi A, Couturier C, Devos JM et al (2001) Java-based graphical user interface for the MRUI quantitation package. Magma 12: 141-152
24. Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22: 696-699
25. Kleiner DE, Brunt EM, Van Natta M et al (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321
26. Asbach P, Klatt D, Schlosser B et al (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257: 80-86
27. Huwart L, Peeters F, Sinkus R et al (2006) Liver fibrosis: noninvasive assessment with MR elastography. NMR Biomed 19: 173-179
28. Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196: 553-561
29. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5: 1207-1213, e1202
30. Everhart JE, Wright EC, Goodman ZD et al (2010) Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51: 585-594
31. Nitta Y, Kawabe N, Hashimoto S et al (2009) Liver stiffness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 39: 675-684
32. O'Brien MJ, Keating NM, Elderiny S et al (2000) An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C. Am J Clin Pathol 114: 712-718
33. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245: 458-466
34. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135: 32-40
35. Yin MGK, Talwalkar JA, Manduca A, Ehman RL (2009) Validity of a 3-D wave field model in MR elastography of the liver. ISMRM, Honolulu, p710
36. Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor- Robinson SD (2003) The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 37: 788-794
37. Noren B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O (2005) Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 15: 148-157
38. Corbin IR, Ryner LN, Singh H, Minuk GY (2004) Quantitative hepatic phosphorus-31 magnetic resonance spectroscopy in compensated and decompensated cirrhosis. Am J Physiol Gastrointest Liver Physiol 287:G379-384
39. Dezortova M, Taimr P, Skoch A, Spicak J, Hajek M (2005) Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J Gastroenterol 11: 6926-6931
40. Kiyono K, Shibata A, Sone S et al (1998) Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy. Acta Radiol 39: 309-314
41. Menon DK, Sargentoni J, Taylor-Robinson SD et al (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 21: 417-427
42. van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WP (1995) 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepatology 21: 443-449